Non-COVID-19-Related Deaths Up, Too
Excess deaths seen for specific gender and age groups, with protective effect seen for female children
Xofluza Approved for Postexposure Prevention of Flu
Influenza infection and symptoms occurred in 1 and 13 percent of those receiving Xofluza and placebo, respectively
Predictors of Late Effects in Young AML Survivors Explored
Most common late effects were endocrine, cardiovascular, respiratory; likelihood of late effects up for those who underwent HSCT
Vegans Have Increased Risk for Total, Main-Site Fractures
Association attenuated slightly with adjustment for dietary calcium and/or protein but still significant
FDA Authorizes Use of Monoclonal Antibody Treatment for COVID-19
IV infusion of casirivimab and imdevimab authorized for treatment of mild-to-moderate COVID-19
Risk for Infection Up for Children Born by C-Section
Increased risk for serious childhood infection following elective, emergency cesarean section persisted to five years
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Teens Increasingly Worried About Their Weight
Large U.K. study shows more teens are dieting, overestimating their weight
